Journal Articles

Pilot study: haemoglobin spray in the treatment of chronic diabetic foot ulcers

Share this article

Pilot study: haemoglobin spray in the treatment of chronic diabetic foot ulcers

Paul Chadwick
7 November 2014

Wounds cannot heal without oxygen. In fact, healing wounds demand more oxygen than healthy tissue — yet chronic wounds are often at least partly due to vascular insufficiency. A novel spray aims to make use of haemogolobin, the transport molecule for oxygen in the bloodstream, to bind atmospheric oxygen and deliver it to the hypoxic wound bed. The product, Granulox® (Infirst Healthcare), may be of particular interest in patients with impaired levels of tissue perfusion/oxygenation, which may be impeding wound healing.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.